Skip to content
PeptideAgent

Compounding pharmacies in Oklahoma

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

The Oklahoma State Board of Pharmacy regulates compounding pharmacies in Oklahoma. Compounded GLP-1 limited. How to check a pharmacy's license, plus verified listings.

Oklahoma at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async unclear
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified compounding pharmacies serving Oklahoma

No verified compounding pharmacies serving Oklahoma are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Who regulates compounding pharmacies in Oklahoma

The Oklahoma State Board of Pharmacy licenses pharmacies under the Oklahoma Pharmacy Act (title 59, section 353 and following) and regulates compounding through Oklahoma Administrative Code title 535, chapter 15. Subchapter 9 (OAC 535:15-9-1 through 535:15-9-12) requires a separate sterile compounding preparation permit, held on top of a retail or non-resident pharmacy license and renewed with it, for every pharmacy compounding sterile preparations such as injectable peptides. Subchapter 10 sets good compounding practices, part 1 for non-sterile preparations (535:15-10-1 and following) and part 3 for sterile preparations (535:15-10-50 and following), and requires every compounding pharmacist to be familiar with USP compounding standards. Oklahoma has not adopted a separate state list of compoundable bulk substances; the Board applies the federal 503A test (approved drug component, USP or NF monograph, or FDA 503A bulks list). Title 59 section 353.18 makes it unlawful to sell prescription drugs or accept prescriptions without a Board license, including when the seller is out of state and the drug is delivered to patients in Oklahoma, and OAC 535:15-3-9 requires a non-resident pharmacy to hold an annual Oklahoma non-resident pharmacy license, keep its home-state license in good standing, submit an inspection report from the prior 24 months, and name an Oklahoma-licensed pharmacist in charge. The Board's license lookup confirms a pharmacy's status. [1] [2] [3] [4] [5]

Compounded GLP-1 access in Oklahoma

Patients using telehealth programs should confirm the dispensing pharmacy holds an Oklahoma pharmacy or nonresident pharmacy license. [1] [8]

Research use only sellers in Oklahoma

Selling injectable peptides labeled "for research use only" to Oklahoma consumers is not a licensed pharmacy activity and is not authorized by the Oklahoma Pharmacy Act, which restricts dispensing of prescription drugs to licensed pharmacies. They carry no Oklahoma consumer protection and no pharmacist oversight. [2] [9]

How to check a compounding pharmacy in Oklahoma

  1. Search the Oklahoma State Board of Pharmacy license lookup for the pharmacy by name. A pharmacy based elsewhere needs whatever license or registration Oklahoma requires before it ships to you. [1] [2] [3] [4] [5]
  2. Ask whether it operates as a 503A pharmacy or a 503B outsourcing facility, and confirm a 503B claim against FDA's outsourcing facility information (see the verification checklist).
  3. Confirm the peptide can be lawfully compounded: check its status on the regulatory tracker or its peptide page before paying.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in Oklahoma. [2] [9]

Common questions in Oklahoma

Can an out-of-state pharmacy ship compounded peptides to me in Oklahoma?

Only if it holds an Oklahoma non-resident pharmacy license issued by the Oklahoma State Board of Pharmacy. Title 59 section 353.18 requires a Board license for out-of-state sellers delivering prescription drugs to Oklahoma patients, and OAC 535:15-3-9 sets the non-resident license requirements; a pharmacy compounding sterile injectables also needs a sterile compounding permit under OAC 535:15-9. Use the Board's license lookup to confirm the pharmacy before paying. [1] [2] [4]

Can an Oklahoma pharmacy compound BPC-157 or other unapproved peptides?

No, not from bulk today. BPC-157 is not on the 503A bulks list. PCAC's July 2026 recommendation is advisory, and until FDA publishes a final rule a 503A pharmacy has no federal basis to compound it from bulk. State boards cannot authorize what federal law does not. Peptides still in FDA Category 2 cannot be compounded either. [3] [6] [7]

All peptide legal questions for Oklahoma

Sources

  1. [1]Oklahoma State Board of Pharmacy
  2. [2]Oklahoma Pharmacy Act, Oklahoma Statutes title 59, section 353.1 (definitions) and following
  3. [3]Oklahoma Administrative Code 535:15-10, Good compounding practices (State Board of Pharmacy)
  4. [4]Oklahoma State Board of Pharmacy: Pharmacy Law Book (title 59 section 353.18; OAC 535:15-3-9, 535:15-9, 535:15-10), updated July 2026
  5. [5]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  6. [6]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA
  7. [7]FDA: Pharmacy Compounding Advisory CommitteeFDA
  8. [8]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  9. [9]21 U.S.C. 331, Prohibited acts